Acetylcholine Release Inhibitors
"Acetylcholine Release Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that block release of the neurotransmitter ACETYLCHOLINE.
| Descriptor ID |
D065087
|
| MeSH Number(s) |
D27.505.519.562.061 D27.505.519.625.120.069 D27.505.696.577.120.069
|
| Concept/Terms |
Acetylcholine Release Inhibitors- Acetylcholine Release Inhibitors
- Inhibitors, Acetylcholine Release
- Acetylcholine Release Antagonists
- Antagonists, Acetylcholine Release
- Acetylcholine Release Blockers
- Blockers, Acetylcholine Release
- Release Blockers, Acetylcholine
|
Below are MeSH descriptors whose meaning is more general than "Acetylcholine Release Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Acetylcholine Release Inhibitors".
This graph shows the total number of publications written about "Acetylcholine Release Inhibitors" by people in this website by year, and whether "Acetylcholine Release Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2014 | 1 | 0 | 1 |
| 2016 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Acetylcholine Release Inhibitors" by people in Profiles.
-
OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial. J Urol. 2017 02; 197(2S):S216-S223.
-
Durable Efficacy and Safety of Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3.5-Year Study. J Urol. 2016 Sep; 196(3):791-800.
-
Toward a Tailored Treatment of Achalasia: An Evidence-Based Approach. J Laparoendosc Adv Surg Tech A. 2016 Apr; 26(4):256-63.
-
Controversies in management of achalasia. J Gastrointest Surg. 2014 Sep; 18(9):1705-9.
-
The Refractory Overactive Bladder: Sacral NEuromodulation vs. BoTulinum Toxin Assessment: ROSETTA trial. Contemp Clin Trials. 2014 Mar; 37(2):272-83.